Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3976679 | Brachytherapy | 2015 | 8 Pages |
Abstract
Prostate seed implants with optimal dosimetry to prostate may still have suboptimal D90 and V100 for the CTV, especially in the presence of postimplant edema. A consensus is needed for definition and evaluation of CTV in postimplant setting for low-dose-rate prostate brachytherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nicola J. Nasser, Joshua Sappiatzer, Yinkun Wang, Jette Borg, Elantholi P. Saibishkumar,